Allied Market Research’s report on “Global Blood Screening Market by Technology (Nucleic Acid Testing (NAT), Elisa, Rapid Tests, Western Blot Assay, and Next-generation Sequencing (NSG)), Product (Reagents & Kits, Instruments, and Software & Services), and End User (Blood Banks and Hospitals) – Global Opportunity Analysis and Industry Forecast, 2018-2025,” says that the global blood screening market is expected to gather a significant CAGR during the forecast period, 2018-2025.
The market study is an in-depth analysis of the blood screening market. It enables the interested business owners and individuals understand the entire market with the help of critical industry insights. It provides an overview of the drivers, restraints, and opportunities impacting the industry. It discusses the market size, share, segmentation, and technology trends that are currently prevailing in this market. It also provides information about the leading players operating in the market.
Download Sample of the Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2826
The report elaborately analyzes the drivers, restraints, and opportunities of the blood screening market. Increase in prevalence of infectious diseases, rise in number of blood donations, increase in consumer awareness of healthcare, rise in healthcare initiatives by government, increase in healthcare expenditure, technological advancements in blood screening technologies, and surge in adoption of nucleic acid amplification test (NAT) drive the growth of the market. However, factors such as stringent regulatory approvals, dearth of skilled manpower, and high operating costs hinder the growth of the industry.
The report emphasizes on the various segments of the blood screening market. The market is segmented into technology, product, end user, and geography. Based on technology, the market is divided into nucleic acid testing (NAT), Elisa, rapid tests, western blot assay, and next-generation sequencing (NSG). The report splits the product type segment into reagents & kits, instruments, and software & services. Based on end user, the market is divided into blood banks and hospitals. The geographical analysis of the market covers the regions such as North America, Europe, Asia-Pacific, and LAMEA.
The key players in the blood screening market are expanding the scope of their business operations in the developing countries by including innovative products in their product portfolios. The report includes a detailed competitive analysis of the major market players, such as Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols, Siemens AG, and Beckman Coulter, Inc.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2826
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Your information will never be shared with any third party.